Discussion about this post

User's avatar
Claustrophilia's avatar

Years ago when I worked at what was then the world’s largest financial services company, our chairman would enjoin us to own “a share of mind” of our customers. It was not as clunky as it sounds. How often and how quickly will our clients turn to us when they have a particular need to be met?

Democrats, in their present parlous state, are looking to increase their share of mind among the electorate. All this supply-side progressivism talk is to make voters associate the Democrats with being the party that most efficiently provides the enabling conditions (now called state capacity) for Americans to pursue the American Dream that neoliberalism has promised them. In that sense, abundance progressivism is the handmaiden of neoliberalism.

But can we do anything about it? Sadly, no. Looking back at the great sweep of American history since it began its industrialization, it’s seems clear to me, albeit belatedly, that a feral kind of capitalism is embedded in the identity of this nation. The state exists to rescue a business and financial sector fuelled by animal spirits when it runs amuck. Only when there is a catastrophic economic crisis that discredits that economic model is there a shift in the relationship between state and society more broadly.

And one could argue that the Great Depression too in the end rolled out a safety net for businesses. In return it asked for a semblance of a welfare state. That side of the bargain had been progressively (sic) shredded since the 1980s. The hubris of the private sector is now so great that it wants to perform its high wire act with no safety net.

Expand full comment
Jay Roshe's avatar

An insightful post. Abundance pairs very well with progressivism and progressive goals, so I'm disheartened by a lot of the infighting, which seems largely unnecessary. I will say a fair number of critics of Abundance clearly didn't read the book. David Austin Walsh admitted he only "read bits and pieces", though I'd wager he didn't read it at all.

My area of interest is medical research targeting aging biology to treat/prevent age-related diseases and increase healthy lifespan. While there has been talk of abundance related to healthcare, especially from the Niskanen Center, medically targeting the biology of aging to fundamentally change 21st-century medicine is still largely unknown, despite fast-growing support; examples includes ARPA-H programs PROSPR to develop aging biomarkers and run FDA clinical trials against them and FRONT to realize functional repair of neocortical tissue. PROSPR is run by a researcher who was a mentor in Longevity Biotech Fellowship, and FRONT is managed by the author of "Replacing Aging."

Expand full comment
6 more comments...

No posts